ORLANDO, Fla.--(BUSINESS WIRE)--Today, ION Solutions, a part of AmerisourceBergen and the largest physician service organization and group purchasing organization (GPO) specializing in the support of community oncology, commenced its inaugural Immuno-Oncology (I-O) Conference. As part of ION and AmerisourceBergen’s commitment to providing critical resources that will ultimately enhance patient care, the conference brings together more than 150 community oncology physicians, nurses, pharmacists and practice administrators with leading manufacturers to share the latest research and clinical advancements in I-O.
“In a breakthrough area like immuno-oncology, we want to ensure that community oncology practices have access to the most progressive therapies and operational resources in order to fully capitalize on these clinical advancements,” said Mark Santos, President, Specialty Physician Services GPOs, AmerisourceBergen. “By leveraging our collective expertise and network to connect our physician practices and manufacturer partners, we can better support the delivery of innovative approaches to treatment and ultimately help to drive access, quality and improved patient outcomes.”
Throughout the two-day conference, providers and patient support staff have the opportunity to attend sessions on the proliferation of I-O drugs and the new wave of treatments, the potential of I-O research, and the development and process of bringing these molecules to market. Oncologist, Medical Director of Informatics Dr. Lucio Gordan with Florida Cancer Specialists & Research Institute will serve as conference moderator. Dr. Gordan will share his insights around how new immunotherapies are changing the landscape when it comes to treating patients.
This conference is part of ION Solutions’ ongoing educational conference series. These sessions are opportunities for peer-to-peer learning and networking, and they are a designed to help strengthen the community of independent physicians dedicated to oncology. Each year, ION hosts nine conferences featuring expert speakers, a review of key clinical findings on specific areas in oncology and thought-provoking discussions related to the latest clinical treatment options and best practices in business operations. ION will host its national conference in Baltimore this November. The national conference will highlight many of ION’s premier programs, including Innovation Cancer as well as its consulting, practice management, technology and in-office dispensing solutions. For more information, please visit www.iononline.com/IonHome.
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work—and powered by our 20,000 associates—we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #11 on the Fortune 500, with more than $145 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. Learn more at amerisourcebergen.com.
About Florida Cancer Specialists & Research Institute
Founded in 1984, Florida Cancer Specialists & Research Institute (FCS) is the largest independent medical oncology/hematology practice in the United States. With over 200 physicians, 160 nurse practitioners and physician assistants and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings close to home. For more information, visit FLCancer.com.